Trial intelligence / Profile preview

Betaine in patients with haemophilia A

DRKS00012899Phase 3Terminated

Sponsor
Goethe University Frankfurt
Start
Sep 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of betaine in hemophilia A (2 arms), sponsored by Goethe University Frankfurt. Started Sep 2017; status: terminated.

02

Drugs

betaine
03

Conditions

hemophilia A

Beyond the preview

Go deeper on DRKS00012899.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00012899.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call